Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase 3 25Phase 1 15Phase 4 11Phase NA 10Phase 1/2 6Phase 2/3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER_GOV 3OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2Metastatic Breast Cancer With Bone Involvement 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Zoledronic Acid × Clear all
NCT01344967 2015-06-23

SuBDuE

University Health Network, Toronto

Phase 2/3 Completed
21 enrolled
Breast

Metastatic Breast Cancer With Bone Involvement

NCT01654367 2012-07-31

esozao

Tianjin Medical University

Phase 2/3 Unknown
300 enrolled
Breast

Breast Neoplasms

NCT00524849 2010-09-14

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Fudan University

Phase 2/3 Completed
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡